These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 37370272)
1. In Vitro Activity of Omadacycline and Comparator Antibiotics against Extended-Spectrum Beta-Lactamase-Producing Stone TJ; Kilic A; Williamson JC; Palavecino EL Antibiotics (Basel); 2023 May; 12(6):. PubMed ID: 37370272 [TBL] [Abstract][Full Text] [Related]
2. Comparative Mirza HC; Güçlü AÜ; İnce Ceviz G; Başustaoğlu A J Med Microbiol; 2022 Oct; 71(10):. PubMed ID: 36301611 [No Abstract] [Full Text] [Related]
3. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin. Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972 [TBL] [Abstract][Full Text] [Related]
4. [Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae]. de Cueto M; Hernández JR; López-Cerero L; Morillo C; Pascual A Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):613-6. PubMed ID: 17194386 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan. Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974 [TBL] [Abstract][Full Text] [Related]
7. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years. Aris P; Boroumand MA; Rahbar M; Douraghi M Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348 [TBL] [Abstract][Full Text] [Related]
8. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems]. Kuzucu C; Yetkin F; Görgeç S; Ersoy Y Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156 [TBL] [Abstract][Full Text] [Related]
9. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam? Moland ES; Sanders CC; Thomson KS J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395 [TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017-2020. Lee YL; Ko WC; Lee WS; Lu PL; Chen YH; Cheng SH; Lu MC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Shao PL; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Tang HJ; Hsueh PR Int J Antimicrob Agents; 2021 Sep; 58(3):106377. PubMed ID: 34166777 [TBL] [Abstract][Full Text] [Related]
11. High prevalence of extended-spectrum beta-lactamase-producing Siriphap A; Kitti T; Khuekankaew A; Boonlao C; Thephinlap C; Thepmalee C; Suwannasom N; Khoothiam K Front Cell Infect Microbiol; 2022; 12():955774. PubMed ID: 36004324 [TBL] [Abstract][Full Text] [Related]
12. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates]. Xiong Z; Zhu D; Zhang Y; Wang F Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910 [TBL] [Abstract][Full Text] [Related]
13. In Vitro Efficacy of Flomoxef against Extended-Spectrum Beta-Lactamase-Producing Ngoi ST; Teh CSJ; Chong CW; Abdul Jabar K; Tan SC; Yu LH; Leong KC; Tee LH; AbuBakar S Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33670224 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum β-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates. Morrissey I; Bouchillon SK; Hackel M; Biedenbach DJ; Hawser S; Hoban D; Badal RE J Med Microbiol; 2014 Apr; 63(Pt 4):556-561. PubMed ID: 24478449 [TBL] [Abstract][Full Text] [Related]
15. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations]. Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China. Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890 [TBL] [Abstract][Full Text] [Related]
17. [Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urine of nonhospitalized patients in the Zagreb region]. Marijan T; Plecko V; Vranes J; Dzepina AM; Bedenić B; Kalenić S Med Glas (Zenica); 2010 Feb; 7(1):46-53. PubMed ID: 20387724 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey. Kiremitci A; Dinleyici EC; Erben N; Durmaz G; Yargic ZA; Aybey AD; Usluer G Expert Opin Pharmacother; 2008 Jun; 9(9):1441-9. PubMed ID: 18518776 [TBL] [Abstract][Full Text] [Related]
19. Extended-Spectrum Beta-Lactamases Producing Escherichia coli and Klebsiella pneumoniae: A Multi-Centric Study Across Karnataka. Rao SP; Rama PS; Gurushanthappa V; Manipura R; Srinivasan K J Lab Physicians; 2014 Jan; 6(1):7-13. PubMed ID: 24696553 [TBL] [Abstract][Full Text] [Related]
20. Nosocomial blood-stream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi. Taneja J; Mishra B; Thakur A; Dogra V; Loomba P J Infect Dev Ctries; 2010 Sep; 4(8):517-20. PubMed ID: 20818104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]